Medindia

X

/K I L L K I L L K I L L -- Roche/

Saturday, May 10, 2008 General News J E 4
Advertisement
We are advised by Roche US that journalists and other readers shouldplease disregard the news release, New Study Demonstrates ACTEMRA(R)(tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid ArthritisPatients, issued earlier today over PR Newswire.

SOURCE Roche
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Stereotaxis' Market Leadership Highlighted at Hear...
S
EUSA Pharma Completes Acquisition Of Cytogen Corpo...